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Objectives: Peritoneal ﬁbrosis (PF) is a recognized complication of long term peritoneal dialysis (PD) and
can lead to ultraﬁltration failure. The most commonly used method to create a PF rat model is an
intraperitoneal injection of 0.1% chlorhexidine gluconate with 15% ethanol. The aim of this study was to
use chlorhexidine digluconate without ethanol, given via a PD catheter, to create a PF rat model.
Material and Methods: PF was induced in Sprague-Dawley rats by 0.5 mL 0.1% chlorhexidine digluconate
in normal saline administered daily for 1 or 2 weeks via a PD catheter. Conventional 4.25% Dianeal
dialysate solution, 30 mL, was administered via a PD catheter and the dwell time was 4 hours. Dialysate
samples (0.5 mL) and blood samples (0.5 mL) were taken at 0 and 4 hours after the dialysate ﬂuid had
been infused to measure glucose and urea. At the end of dialysis, the rats were sacriﬁced; the parietal
peritonea of the liver and anterior abdominal wall muscle were harvested. The peritoneum was analyzed
by microscopic examination and immunohistochemistry for transforming growth factor-b1 (TGF-b1),
a-smooth muscle actin (a-SMA), ﬁbronectin, collagen, and vascular endothelial growth factor (VEGF).
Results: After 4 hours of PD, the D4/D0 glucose level was increased, the D4/D4 urea level was decreased,
the liver and muscle peritoneum was markedly thicker, and expression of TGF-b1, a-SMA, ﬁbronectin,
collagen, and VEGF-positive cells was increased in the PF groups compared with the vehicle groups, and
also in the 2 week PF group compared with the 1 week PF group.
Conclusion: We developed a novel method of creating a PF rat model using chlorhexidine digluconate
without ethanol via a PD catheter, which will be useful in the study of PF.
Copyright  2012, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Peritoneal ﬁbrosis (PF) is one of the most serious complications
of peritoneal dialysis (PD) [1,2]. PF is characterized by activation of
the peritoneal resident cells, accumulation and deposition of excess
matrix proteins within the interstitium, and neoangiogenesis and
vasculopathy of the peritoneal microvasculature [3,4]. Studies have
shown that the causes of these peritoneal changes include repeated
episodes of infectious peritonitis, and low biocompatibility of PD
solutions, particularly those which are hyperosmotic, and have
a high glucose concentration, lactate content, low pH, glucose
degradation products, and advanced glycation end-products [5,6].
To date, there are no randomized controlled trials to guide therapy
for PF [2].y, Buddhist Tzu Chi General
aiwan. Tel.: þ886 3 8561825;
).
ddhist Compassion Relief Tzu ChiThe most commonly used method to create a PF rat model is an
intraperitoneal injection of 0.1% chlorhexidine gluconate with 15%
ethanol [7,8]. Increased expression of transforming growth factor-
beta 1 (TGF-b1), alpha-smooth muscle actin (a-SMA), type I
collagen (collagen) and vascular endothelial growth factor (VEGF)
have been observed in the peritoneum of this model [9e12].
However, this technique is cumbersome and requires the use of 15%
ethanol as a control. Another problem is intraperitoneal chlorhex-
idine gluconate administration in rats may unintentionally result in
injection into the abdominal organs, which could have misleading
effects on results. Previously, our studies used renin-angiotenison
system inhibitors (aliskiren, valsartan, enalapril) to ameliorate
chlorhexidine digluconate-induced liver PF in rats [13e15]. These
papers used chlorhexidine digluconate without ethanol for 7 days
and did not show the change of anterior abdominal wall muscle
peritoneum histopathology [13e15]. In this study, chlorhexidine
digluconate without ethanol was used for 7 or 14 days and further
studied in the anterior abdominal wall muscle peritoneum histo-
pathology. The aim of this study was to use chlorhexidineFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
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rat model for 1 or 2 weeks, and to investigate the peritoneal
function, liver and anterior abdominal wall muscle peritoneum
histopathology, and TGF-b1, a-SMA, ﬁbronectin, collagen, and VEGF
immunohistochemistry (IHC) in the liver peritoneum.
2. Material and methods
2.1. Preparation of animals and peritoneal tube insertion
Thirty-two male Sprague-Dawley rats weighing 280e300 g
were purchased from the National Animal Center (Taipei, Taiwan)
and housed in the university animal center in a controlled envi-
ronment at a temperature of 22  1C with a 12 hour light/dark
cycle. Food and water were given ad libitum. The experimental
protocol was approved by the Animal Care and Use Committee of
Tzu Chi University. These animals were anesthetized with halo-
thane inhalation for about 15 minutes. During anesthesia, the fur
over the abdominal wall was closely shaved. A polyethylene cath-
eter (PE-240; PD catheter), about 30 cm long, was inserted about
4 cm into the peritoneal cavity through amidline incision below the
xiphoid process. Then the catheter was tunneled subcutaneously to
the right inguinal area. All procedures were carried out in sterile
conditions. Sterilized stainless steel covers were used to cover the
PD catheter to prevent the rats from biting and dislocating the
catheters. After the operation, the animals were placed in
a conscious rat metabolic cage (Mike Biological Technologies,
Hualien, Taiwan). Rats awakened soon after the operation and PF
was induced 24 hours later, with the rats in a conscious state
[13e15].
2.2. Peritoneal ﬁbrosis (PF)
PF was induced by 0.5 mL 0.1% chlorhexidine digluconate
(Sigma-Aldrich, St. Louis, MO, USA) in normal saline administered
via a PD catheter followed by 1 mL of normal saline daily [13e15].
2.3. Experimental design
The experimental rats were randomly divided into four groups.
The 1 week vehicle group (n ¼ 8) and 2 week vehicle group (n ¼ 8)
received 0.5 mL normal saline via a PD catheter followed by 1 mL of
normal saline daily for 1 week and 2 weeks, respectively. The
1 week PF group (n ¼ 8) and 2 week PF group (n ¼ 8) received
0.5mL 0.1% chlorhexidine digluconate in normal saline, followed by
1 mL of normal saline via the PD catheter daily for 1 week and
2 weeks, respectively.
2.4. Peritoneal dialysis
After the end of PF (7 days or 14 days later), these animals were
anesthetized with ether inhalation for about 15 minutes. After
anesthesia, a polyethylene catheter (PE-50) was inserted into the
right femoral artery for blood sampling. The operation was
completed within 15 minutes, leaving a small wound (<0.5 cm2).
Sterilized stainless steel covers were used to cover the femoral vein
PE catheters to prevent the rats from biting and dislocating the
catheters. After the operation, the animals were placed in
a conscious rat metabolic cage. Rats awakened soon after the
operation and peritoneal dialysis was induced 24 hours later, with
the rats in a conscious state [13e15]. Rats were given conventional
4.25% glucose-containing peritoneal ﬂuid (Dianeal; Baxter Health-
care SA, Singapore Branch, Singapore) 30 mL via the PD catheter to
the rat peritoneal cavity and the dwell time was 4 hours. After
4 hours PD, the animals were sacriﬁced for pathology.2.5. Blood and dialysate ﬂuid sample analysis
Blood and dialysate ﬂuid samples (0.5 mL) were collected for
measurement of glucose and urea at 0, and 4 hours after PD. Part of
the blood and dialysate ﬂuid samples was immediately centrifuged
at 3000 g for 10 minutes within 1 hour after collection for
biochemical analysis. Serum and dialysate ﬂuid levels of glucose
and ureaweremeasuredwith an autoanalyzer (COBAS Integra C111,
Roche Diagnostics, Basel, Switzerland) to obtain various biochem-
ical data [13e15]. The other part of the serum collected at 4 hours
after PD, was stored at 80C for later measurement of TGF-b1
concentrations.
2.6. Serum and dialysate TGF-b1 measurement by ELISA
At 4 hours of PD, TGF-b1 concentrations in the blood and dial-
ysate samples were measured separately by antibody enzyme-
linked immunosorbent assay (ELISA) with commercial antibody
pairs, recombinant standards, and a biotin-streptavidin- peroxidase
detection system (Assay Designs, Ann Arbor, Michigan, USA) as
described previously [13e15]. All reagents, samples, and working
standards were brought to room temperature and prepared
according to the manufacturer’s directions. Reactions were quan-
tiﬁed by optical density using an automated ELISA reader (Sunrise,
Tecan Co., Grödingen, Austria) at a 450/540 nm wavelength.
2.7. Peritoneal solutes transport analysis
Peritoneal solute transport was calculated from the dialysate
concentration relative to its concentration in the initial infused
dialysis solution (D4/D0 glucose) for glucose, and the dialysate-to-
plasma concentration ratio (D4/P4 urea) at 4 hours for urea
[11,13e15].
2.8. Histological assessment
The anterior abdominal wall muscle peritoneum and liver
peritoneum were ﬁxed overnight in 4% buffered formaldehyde,
processed by standard methods, and stained with hematoxylin and
eosin. Both parietal and visceral peritoneal surfaces were evaluated
by morphometry and IHC. Thickening of the muscle peritoneum
and liver peritoneum was deﬁned from the abdominal muscular
surface or the liver surface to the peritoneal cavity. Quantiﬁcation of
the liver and muscle peritoneum was performed on parafﬁn-
embedded tissue sections and was counted digitally using a 200
objective lens via a computer imaging analysis system (Image-Pro
Plus 4.5, Media Cybernetics, Bethesda, MD, USA) as described
previously [11,13e15]. Brieﬂy, the thickness of the muscle perito-
neum and liver peritoneum was measured at 10 points in each rat.
2.9. Immunohistochemistry (IHC)
For IHC of the liver peritoneum, serial 4 mm sections were
deparafﬁnized, rehydrated, and incubated with different mouse
monoclonal antibodies at 4C overnight according to the manu-
facturer’s directions. Antigen retrieval was used for TGF-b1 (Abcam,
Cambridge, MA, USA), ﬁbronectin, collagen (Rockland Immuno-
chemicals Inc., Gilbertsville, PA, USA), VEGF and a-SMA (Bio SB,
Santa Barbara, CA, USA). Dilutions were 1 in 100 for all ﬁve
immunohistochemical factors. After incubation, tissue sections
were covered with biotinylated goat anti-mouse polyvalent
secondary antibody and incubated at room temperature for 10
minutes. After washing, the slides were incubated in peroxidase
conjugated streptavidin-biotin complex (Dako, Copenhagen,
Denmark) for 10 minutes. The cells positive for TGF-b1, a-SMA,
Fig. 1. The D4/D0 glucose level (A) and D4/P4 urea level (B) in chlorhexidine digluconate-induced peritoneal ﬁbrosis (PF). *p < 0.05 for the 1 week PF group compared with the
1 week vehicle group. þp < 0.05 for the 2 week PF group compared with the 2 week vehicle group. #p < 0.05 for the 2 week PF group compared with the 1 week PF group.
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magniﬁcation ﬁeld; 0.1 mm width  0.1 mm height) were evalu-
ated for four ﬁelds, and were counted digitally via a computer
imaging analysis system (Image-Pro Plus 4.5); results are reported
as the percentage of positive cells/mm2 of peritoneal tissue
[13e15]. All scoring was performed in a blinded manner on coded
slides.
2.10. Statistical analysis
Data were expressed as mean  SD. Statistical comparisons
between different groups at corresponding time points were made
by repeated measures two-way ANOVA followed by a post hoc test
(Bonferroni’s method). Histological scores were analyzed by the
Kruskal-Wallis test followed by theMann-Whitney U test. A p value
<0.05 was considered statistically signiﬁcant.
3. Results
3.1. Peritoneal function
All rats survived during the procedure for administration of
0.5 mL normal saline or 0.5 mL 0.1% chlorhexidine digluconate. The
D4/D0 glucose level was signiﬁcantly higher, and D4/P4 urea level
was signiﬁcantly lower in the 1 week PF group compared with the
1 week vehicle group (*p< 0.05; Fig. 1A and B) and in the 2 week PF
group compared with the 2 week vehicle group (þp < 0.05; Fig. 1A
and B). The D4/D0 glucose level was signiﬁcantly higher, and D4/P4
urea level was signiﬁcantly lower in the 2week PF group than in the
1 week PF group (#p < 0.05; Fig. 1A and B).Fig. 2. Serum (A) and dialysate (B) transforming growth factor-beta 1 (TGF-b1) levels after
week PF group compared with the 1 week vehicle group. þp < 0.05 for the 2 week PF group
with the 1 week PF group.3.2. Serum and dialysate TGF-b1 level
PF greatly elevated the serum and dialysate TGF-b1 levels
compared with the vehicle groups (Fig. 2A and B). The serum and
dialysate TGF-b1 levels in the 1 week PF group were higher than
those in the 1 week vehicle group (*p < 0.05; Fig. 2A and B), and
those in the 2 week PF group were higher than those in the 2 week
vehicle group (þp < 0.05; Fig. 2A and B). Moreover, the serum and
dialysate TGF-b1 levels were higher in the 2 week PF group than
those in the 1 week PF group (#p < 0.05; Fig. 2A and B).
3.3. Histopathology of liver and muscle peritoneum
Daily administration of chlorhexidine digluconate induced
thickness of the liver and muscle peritoneum (Figs. 3C, 3D, 4C, and
4D). The liver peritoneum and muscle peritoneum were thicker in
the 1 week PF group than in the 1 week vehicle group (*p < 0.05;
Figs. 3E and 4E), in the 2 week PF group than in the 2 week vehicle
group (þp < 0.05; Figs. 3E and 4E), and in the 2 week PF group than
in the 1 week PF group (#p < 0.05; Figs. 3E and 4E).
3.4. IHC of liver peritoneum
The numbers of TGF-b1-positive, a-SMA-positive, ﬁbronectin-
positive, collagen-positive, and VEGF-positive cells in the same
square area were increased in the chlorhexidine digluconate-
induced PF groups compared with the vehicle groups (Fig. 5).
More cells were positive for all ﬁve of these immunohistochemical
factors in the 1 week PF group than in the 1 week vehicle group
(*p < 0.05; Fig. 6AeE), in the 2 week vehicle group than in thechlorhexidine digluconate-induced peritoneal ﬁrbosis (PF) in rats. *p < 0.05 for the 1
compared with the 2 week vehicle group. #p < 0.05 for the 2 week PF group compared
Fig. 3. Hematoxylin and eosin staining of the liver peritoneum. Histologic sections from the 1 week vehicle group (A), 2 week vehicle group (B), 1 week peritoneal ﬁbrosis (PF) group
(C), and 2 week PF group (D) (magniﬁcation  200). Thickness of the liver peritoneum after chlorhexidine digluconate-induced PF in rats (E). *p < 0.05 for the 1 week PF group
compared with the 1 week vehicle group. þp < 0.05 for the 2 week PF group compared with the 2 week vehicle group. #p < 0.05 for the 2 week PF group compared with the 1 week
PF group. Bar ¼ 40 mm.
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group than in the 1 week PF group (#p < 0.05; Fig. 6AeE).
4. Discussion
The availability of adequate experimental models of PF is
essential to the development and testing of therapeutic approaches
for patients with PF. In this study, 0.5 mL 0.1% chlorhexidine
digluconate without ethanol administered daily via a PD catheter
resulted in signiﬁcantly thicker liver and muscle peritoneum, andsigniﬁcantly increased expression of TGF-b1,a-SMA, ﬁbronectin,
collagen, and VEGF-positive cells compared with vehicle adminis-
tration. Moreover, the 2week PF group hadmore severe PF than the
1 week PF group.
PF is one of the most serious complications of long-term PD [8].
Studies of PF in rats have focused on chronic exposure to chlo-
rhexidine gluconate, acid glucose solution, and povidone iodine,
and have demonstrated chemical irritation, sterile peritonitis, and
chronic inﬂammation [1,8]. The most commonly used method to
create the PF rat model is intraperitoneal injection of 0.1%
Fig. 4. Hematoxylin and eosin staining of the muscle peritoneum. Histologic sections from the 1 week vehicle group (A), 2 week vehicle group (B), 1 week peritoneal ﬁbrosis (PF)
group (C), and 2 week PF group (D) (magniﬁcation  200). Thickness of the muscle peritoneum after chlorhexidine digluconate-induced PF in rats (E). *p < 0.05 for the 1 week PF
group compared with the 1 week vehicle group. þp < 0.05 for the 2 week PF group compared with the 2 week vehicle group. #p < 0.05 for the 2 week PF group compared with the
1 week PF group. Bar ¼ 40 mm.
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daily injections for 3 weeks [7,8,16,17]. Acetaldehyde, the ﬁrst
metabolite of ethanol, can affect collagen I production by upregu-
lating the synthesis of TGF-b1 [18]. Acetaldehyde also induces rat
hepatic stellate cells to increase a-SMA and TGF-b1 production [19].
Ethanol elevates the activities of VEGF and TGF-b1 [20]. Our model
is different, because chlorhexidine digluconate was used as
a chemical irritant to induce PF and ethanol was not used as
a control solution, which avoids the effects of ethanol on the
synthesis of TGF-b1. A PD catheter was used instead of intraperi-
toneal injections, to avoid administration into the abdominalorgans. Another advantage of our PF model is that chlorhexidine
digluconate was administered for only 7 days and it could still
induce signiﬁcant PF in rats.
In long-term PD, morphological and functional changes in the
peritoneal membrane are common. Submesothelial ﬁbrosis,
angiogenesis, vasculopathy, and collagen deposition are typical
histomorphological alterations in the peritoneal membrane
[3,6,21]. Major pathways of PF are most likely related to TGF-b
and VEGF, which can stimulate transformation of mesothelial
cells to myoﬁbroblasts and initiate PF [1,8]. Repeated injuries to
the peritoneum from chemical irritants lead to denudation of
Fig. 5. Immunohistochemical staining for (TGF-b1; A, B, C, D), alpha-smooth muscle actin (a-SMA; E, F, G, H), ﬁbronectin (I, J, K, L), collagen (M, N, O, P), and vascular endothelial
growth factor (VEGF; Q, R, S, T) in the liver peritoneum. Histological sections from the 1 week vehicle group (A, E, I, M, Q), 2 week vehicle group (B, F, J, N, R), 1 week peritoneal
ﬁbrosis (PF) group (C, G, K, O, S), and 2 week PF group (D, H, L, P, T) (magniﬁcation  200) after chlorhexidine digluconate-induced peritoneal ﬁbrosis in rats.
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phages and mononuclear cells and promotion of epithelial-to-
mesenchymal transition, which provides more activated
ﬁbroblasts, progressing later to collagen deposition and ﬁbrosis
[2,8,22]. Our study noted the increased thickening of the liver
and muscle peritoneum, and increased expression of TGF-b1,
a-SMA, ﬁbronectin, collagen, and VEGF-positive cells in the PFgroup. Moreover, the 2 week PF group had more severe PF than
the 1 week PF group.
The peritoneal function test is a semiquantitative assessment of
the transport capacity of the peritoneal membrane determined
by the speed of equilibration of the concentrations of a solute
between the plasma and the dialysis solution [23]. The concen-
tration ratio between dialysate and plasma (D/P) of a given solute,
Fig. 6. The percentages of transforming growth factor-beta 1 (TGF-b1)-positive cells: (A) alpha-smooth muscle actin (a-SMA)-positive cells; (B) ﬁbronectin-positive cells (C)
collagen-positive cells (D), and vascular endothelial growth factor (VEGF)-positive cells score (E) in the liver peritoneum after chlorhexidine digluconate-induced (PF) in rats.
*p < 0.05 for the 1 week PF group compared with the 1 week vehicle group. þp < 0.05 for the 2 week PF group compared with the 2 week vehicle group. #p < 0.05 for the 2 week PF
group compared with the 1 week PF group.
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the concentrations. A high solute D/P means that the balance
between dialysate and plasma is reached quickly, and therefore the
peritoneal permeability for the solute is high. In our study, the D4/
P4 urea level was signiﬁcantly lower in the 1 week PF group than in
the 1 week vehicle group, and in the 2 week PF group than in the
2 week vehicle group. Moreover, the D4/P4 urea level was signiﬁ-
cantly lower in the 2 week PF group than in the 1 week PF group.
This means that PF-induced plasma urea could not transport to thedialysate and the peritoneal permeability for the urea was low. The
ratio between the concentration of glucose in the dialysate after
a certain time (t) and the concentration of glucose in the dialysate
at the beginning of the test (Dt/D0) is also used [23]. In our study,
the D4/D0 glucose level was signiﬁcantly higher in the 1 week PF
group than in the 1week vehicle group, in the 2week PF group than
in the 2 week vehicle group, and in the 2 week PF group than in the
1 week PF group. This means that PF-induced dialysate glucose
could not penetrate to the plasma and the peritoneal permeability
R.-P. Lee et al. / Tzu Chi Medical Journal 24 (2012) 108e115 115for the glucose was low. So, in this model, peritoneal solute trans-
port was impaired by PF induced by chlorhexidine digluconate
without ethanol.
The advantages of our PF model are the use of a PD catheter to
administer a chemical irritant, no use of ethanol as a control
solution, and daily administration of chlorhexidine digluconate for
7 days to induce signiﬁcant PF. In the conscious rat model in our
previous studies, a PD catheter was inserted to peritoneal cavity
and a PE-50 catheter was inserted into the femoral artery for blood
samples, and to record the arterial pressure and heart rate and
another PE-50 catheter was inserted into the femoral vein for
intravenous administration of drugs or ﬂuid [13e15]. Our model
can further study a drug’s effects on PF and allow blood data and
hemodynamic changes to be monitored over a time course without
anesthesia.Acknowledgments
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